Pharmaceutical Technology1 天
Obrixtamig by Boehringer Ingelheim International for Small-Cell Lung Cancer: Likelihood of ...
Obrixtamig is under clinical development by Boehringer Ingelheim International and currently in Phase I for Small-Cell Lung Cancer.
Pharmaceutical Technology1 天
BI-765049 by Boehringer Ingelheim International for Non-Small Cell Lung Cancer: Likelihood ...
BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Non-Small Cell Lung Cancer.
Warning Signs Of Cancer That Can Appear In Women
New moles, changes in existing moles, or spots that bleed and don't heal can be signs of skin cancer. Women, especially those ...